The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral...
Read moreThe U.S. Food and Drug Administration, FDA approves Brinsupri, Insmed's oral drug for a lung disease, the company announced. This...
Read moreThe U.S. Food and Drug Administration has officially approved a new brain tumour treatment developed by Jazz Pharmaceuticals. The medication,...
Read moreEverest Medicines, a biopharmaceutical company dedicated to advancing innovative therapies, has announced that Taiwan’s Food and Drug Administration (TFDA) has...
Read moreAptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the...
Read moreBio-Thera Solutions announced that the FDA has accepted its Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi®...
Read moreThe US Food and Drug Administration (FDA) has approved the first on-demand oral therapy for the treatment of acute attacks...
Read moreAvadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced on June 5 2025, that LUMRYZTM...
Read moreThe US FDA is now tightening its regulatory policy around COVID vaccines by setting up a new framework that raises...
Read moreGlobal Biopharma Market Forecasts $566B By 2032 opposing Challenges With a compound annual growth rate of almost 8%, from $263...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.